𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia

✍ Scribed by Anna Sarkozy; Emanuela Conti; Rita D'Agostino; Maria Cristina Digilio; Roberto Formigari; Fernando Picchio; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
51 KB
Volume
133A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mutations of ZFPM2/FOG2 gene in sporadic
Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot
✍ Antonio Pizzuti; Anna Sarkozy; Anthea L. Newton; Emanuela Conti; Elisabetta Flex πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

FIGURE 3. The E30S and S657G mutations do not signiΒ’cantly impair binding to the partner protein GATA4. A: GST pull-down assay showing retention of wild-type ZFPM2/FOG2, the E30S and S657G mutants by GATA4 N-Β’nger. Input lanes show that equivalent amounts of wild-type and mutant ZFPM2/FOG2 proteins

Mutations of ZFPM2/FOG2 gene in sporadic
Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot
✍ Antonio Pizzuti; Anna Sarkozy; Anthea L. Newton; Emanuela Conti; Elisabetta Flex πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Communicated by Arnold Munnich Two out of 47 patients with sporadic tetralogy of Fallot (TOF), the most common cyanotic conotruncal heart defect (CTD), showed heterozygous missense mutations of the ZFPM2/FOG2 gene. Knockout mice carrying mutations in the ZFPM2/FOG2 gene have similarly been foun

Expression and mutational analysis of th
Expression and mutational analysis of theMADR2/smad2 gene in human prostate cancer
✍ Latil, Alain; Pesche, Sandrine; ValοΏ½ri, Antoine; Fournier, Georges; Cussenot, Ol πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 2 views

BACKGROUND. Loss of heterozygosity (LOH) on chromosome arm 18q is common in sporadic prostate cancer and may be involved in cancer development through inactivation of tumor-suppressor genes (TSG). Recent identification, at 18q21.1, of MADR2/Smad2, a key component in transforming growth factor ␀ (TGF